TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9585310

Group type: EXPERIMENTAL
Intervention: Clonidine 0.2-0.3 mg per os
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 7712843

Group type: EXPERIMENTAL
Intervention: 120mg calcium daily
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: 240mg calcium daily
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: 1g calcium daily
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: 2g calcium daily
Number of subjects: 212

Group type: COMPARATOR
Intervention: Control group (no calcium supplementation)
Number of subjects: 212

Group type: COMPARATOR
Intervention: Control group (non-calcium supplementation cases)
Number of subjects: 212
Study: 2719293

Group type: EXPERIMENTAL
Intervention: 0.5 ml saline solution and 0.5 ml clonidine (75 micrograms)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: 1 ml clonidine (150 micrograms)
Number of subjects: 44

Group type: COMPARATOR
Intervention: 15 mg of 0.5% hyperbaric tetracaine (HT) + 1 ml isotonic saline
Number of subjects: 44
Study: 785915

Group type: EXPERIMENTAL
Intervention: Dexon sutures
Number of subjects: 308

Group type: COMPARATOR
Intervention: Mersilene sutures
Number of subjects: 308
Study: 29654915

Group type: EXPERIMENTAL
Intervention: MaZiRenWan (MZRW) 7.5 g, twice daily
Number of subjects: 291

Group type: COMPARATOR
Intervention: Senna 15 mg daily
Number of subjects: 291

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 291
Study: 28982816

Group type: EXPERIMENTAL
Intervention: Direct transport to specialist neuroscience centres (SNCs) bypassing nearest non-specialist acute hospitals (NSAHs)
Number of subjects: 293

Group type: COMPARATOR
Intervention: Transport to nearest NSAH with selective secondary transfer to SNC
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: Direct transport to SNCs bypassing nearest NSAHs
Number of subjects: 293
Study: 26618469

Group type: EXPERIMENTAL
Intervention: Merz Hand Grading Scale (MHGS)
Number of subjects: 84
Study: 23358971

Group type: EXPERIMENTAL
Intervention: Exemestane
Number of subjects: 7576

Group type: COMPARATOR
Intervention: Anastrozole
Number of subjects: 7576

Group type: EXPERIMENTAL
Intervention: Exemestane and Anastrozole
Number of subjects: 7576
Study: 22078420

Group type: COMPARATOR
Intervention: SAVR
Number of subjects: 442

Group type: COMPARATOR
Intervention: TAVI
Number of subjects: 442

Group type: EXPERIMENTAL
Intervention: MT
Number of subjects: 442
Study: 19589305

Group type: EXPERIMENTAL
Intervention: Flatfoot group
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 25
Study: 16840386

Group type: EXPERIMENTAL
Intervention: Enalapril (ACE inhibitor group)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard therapy with ferrous sulfate, 525 mg
Number of subjects: 40
Study: 12867205

Group type: EXPERIMENTAL
Intervention: Methadone treatment (mean daily dose 50 mg) in general practice
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Methadone treatment (mean daily dose 50 mg) in specialist clinics
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 240
Study: 10709792

Group type: EXPERIMENTAL
Intervention: Nutrition education
Number of subjects: 732

Group type: COMPARATOR
Intervention: Stress management classes (attention-placebo group)
Number of subjects: 732
Study: 9209246

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of 500 mg azithromycin
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Oral administration of two 250 mg azithromycin capsules
Number of subjects: 12
Study: 8221740

Group type: EXPERIMENTAL
Intervention: Gallopamil (GAL) 50 mg tid
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Amlodipine (AML) 10 mg/daily
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 3550031

Group type: EXPERIMENTAL
Intervention: Bupivacaine
Number of subjects: 99
Study: 30717693

Group type: EXPERIMENTAL
Intervention: Test & Treat TB intervention with immediate GeneXpert testing; participants received expedited TB treatment initiation, monthly SMS reminders, and non-cash incentives.
Number of subjects: 4815

Group type: COMPARATOR
Intervention: Usual mobile unit care (providing sputum on the mobile unit sent out for GeneXpert testing).
Number of subjects: 4815
Study: 29101973

Group type: EXPERIMENTAL
Intervention: Web-based interactive report
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Patient letter
Number of subjects: 193

Group type: COMPARATOR
Intervention: Standard report
Number of subjects: 193
Study: 25483170

Group type: EXPERIMENTAL
Intervention: Community Walking Training Program (CWTP) for 30 min per day, five times a week, for four weeks
Number of subjects: 22

Group type: COMPARATOR
Intervention: Standard rehabilitation program (physical and occupational therapy for 60 min per day, five times a week, for four weeks)
Number of subjects: 22
Study: 23159962

Group type: EXPERIMENTAL
Intervention: 6 mL bupivacaine 0.125% and 8 mg dexamethasone in a total volume of 8 mL (Group 2)
Number of subjects: 64

Group type: COMPARATOR
Intervention: 8 mL saline (Group 1)
Number of subjects: 64
Study: 19041254

Group type: EXPERIMENTAL
Intervention: Self management group using CoaguChek
Number of subjects: 62

Group type: COMPARATOR
Intervention: Conventional group controlled by the Local Thrombosis Service
Number of subjects: 62
Study: 17880315

Group type: EXPERIMENTAL
Intervention: Peripherally inserted central catheter
Number of subjects: 74

Group type: COMPARATOR
Intervention: Peripheral intravenous catheter
Number of subjects: 74
Study: 12766625

Group type: COMPARATOR
Intervention: Ethanol (0.5 g/kg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: d-Amphetamine (0, 5, 10, and 15 mg)
Number of subjects: 16
Study: 11912811

Group type: EXPERIMENTAL
Intervention: DCCT protocol implementation with a diabetes clinical nurse specialist program coordinator
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: DCCT protocol implementation
Number of subjects: 124
Study: 8741076

Group type: EXPERIMENTAL
Intervention: levodopa methyl ester (LDME)
Number of subjects: 34
Study: 1330761

Group type: EXPERIMENTAL
Intervention: Calcitonin
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Estrogen/progestogen (HRT) plus calcitonin
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Estrogen/progestogen (HRT)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 104
Study: 3936140

Group type: EXPERIMENTAL
Intervention: Almitrine bismesylate (200 mg/day for 9 days)
Number of subjects: 18
Study: 3726048

Group type: EXPERIMENTAL
Intervention: Aerobic training
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Anaerobic training (weight-lifting)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 38
Study: 31375462

Group type: EXPERIMENTAL
Intervention: Nutritional information provided to half of the participants (n=150)
Number of subjects: 290

Group type: COMPARATOR
Intervention: No nutritional information provided (control group)
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Chocolate consumption
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Self-reported hunger prior to the study
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Nutritional information
Number of subjects: 290
Study: 29618841

Group type: EXPERIMENTAL
Intervention: Aliskiren
Number of subjects: 39

Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 39
Study: 28585143

Group type: EXPERIMENTAL
Intervention: Single-allergen sublingual immunotherapy (SLIT) with a single HDM extract
Number of subjects: 78

Group type: COMPARATOR
Intervention: Multi-allergen subcutaneous immunotherapy (SCIT) with multiple-allergen extracts (HDM and other allergens)
Number of subjects: 78
Study: 26121900

Group type: EXPERIMENTAL
Intervention: Subtenon bupivacaine 0.5%
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline injection (control)
Number of subjects: 60
Study: 23640321

Group type: EXPERIMENTAL
Intervention: Proprioceptive resistance training (PRT)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Resistance training (RT)
Number of subjects: 26
Study: 20087780

Group type: EXPERIMENTAL
Intervention: Robotic tumor-specific rectal surgery (RTSRS)
Number of subjects: 143
Study: 19034219

Group type: EXPERIMENTAL
Intervention: ATG-Fresenius (9 mg/kg day 0; 3 mg/kg day 1-4)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Daclizumab (1 mg/kg day 0, 14, 28, 42, 56)
Number of subjects: 22
Study: 16598296

Group type: EXPERIMENTAL
Intervention: 1000 mg Altastaph/kg
Number of subjects: 206

Group type: COMPARATOR
Intervention: 0.45% NaCl placebo
Number of subjects: 206
Study: 12947437

Group type: EXPERIMENTAL
Intervention: Filtered coffee 600 ml/day for 4 weeks
Number of subjects: 121

Group type: COMPARATOR
Intervention: Coffee abstention for 3 weeks
Number of subjects: 121
Study: 10625238

Group type: EXPERIMENTAL
Intervention: First hepatic artery revascularization
Number of subjects: 59

Group type: COMPARATOR
Intervention: First portal vein revascularization
Number of subjects: 59
Study: 9100202

Group type: EXPERIMENTAL
Intervention: Tetracycline hydrochloride (50 mg/ml) root treatment for 5 minutes (TTC‐HCl group)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Citric acid root treatment for 3 minutes (CA group)
Number of subjects: 30
Study: 7903034

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine and sulphasalazine combination treatment
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine alone
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Sulphasalazine alone
Number of subjects: 91

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 91
Study: 3861844

Group type: EXPERIMENTAL
Intervention: Multivitamin and mineral supplements
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 31916533

Group type: EXPERIMENTAL
Intervention: Conventional pharmacological treatment plus respiratory physiotherapy (breathing and airway clearance techniques, exercise training, education for 3 weeks, 3 times per week)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Conventional pharmacological treatment (control group)
Number of subjects: 97
Study: 30593551

Group type: EXPERIMENTAL
Intervention: Genetic counselling and disclosure of estimated future cardiovascular risk based on genetic testing results.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard patients' education programme without genetic counselling.
Number of subjects: 0
Study: 27538798

Group type: EXPERIMENTAL
Intervention: HFOV recruitment maneuver (IN-REC-SUR-E)
Number of subjects: 206

Group type: COMPARATOR
Intervention: No recruitment maneuver (IN-SUR-E)
Number of subjects: 206
Study: 24984177

Group type: EXPERIMENTAL
Intervention: Indapamide sustained-release 1.5 mg with the addition of perindopril 2-4 mg as required
Number of subjects: 3845
Study: 23324363

Group type: EXPERIMENTAL
Intervention: Rod colostomy
Number of subjects: 42

Group type: COMPARATOR
Intervention: Skin bridge colostomy
Number of subjects: 42
Study: 20302646

Group type: EXPERIMENTAL
Intervention: Whole grain diet
Number of subjects: 20

Group type: COMPARATOR
Intervention: Refined grain diet
Number of subjects: 20
Study: 18245142

Group type: EXPERIMENTAL
Intervention: SFC+TIO (salmeterol/fluticasone propionate + tiotropium bromide)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: SFC+TIO
Number of subjects: 41

Group type: COMPARATOR
Intervention: TIO
Number of subjects: 41

Group type: COMPARATOR
Intervention: SFC
Number of subjects: 41
Study: 16024091

Group type: EXPERIMENTAL
Intervention: Antidepressant treatment with paroxetine
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Antidepressant treatment with amitriptyline
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control group (11 healthy male subjects)
Number of subjects: 78
Study: 12475578

Group type: EXPERIMENTAL
Intervention: Diabetic pregnancy (n=16)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Normal pregnancy (n=12, n=15, n=15)
Number of subjects: 57
Study: 11105495

Group type: EXPERIMENTAL
Intervention: High dose prednisolone treatment
Number of subjects: 9
Study: 8800303

Group type: EXPERIMENTAL
Intervention: Fluconazole 150 mg once weekly
Number of subjects: 36

Group type: COMPARATOR
Intervention: Griseofulvin 1,000 mg once daily
Number of subjects: 36
Study: 1622115

Group type: COMPARATOR
Intervention: 5-FU
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: 5-FU + FA
Number of subjects: 64
Study: 6324587

Group type: EXPERIMENTAL
Intervention: Prophylactic intravenous administration of hyperimmune cytomegalovirus IgG at a dose of 200 mg/kg on days 25, 50, and 75 following transplant
Number of subjects: 0

Group type: COMPARATOR
Intervention: Supporting treatment control group
Number of subjects: 0
Study: 30920117

Group type: EXPERIMENTAL
Intervention: Four-drug metronomic chemotherapy regimen (oral celecoxib b.i.d., weekly vinblastine, oral cyclophosphamide for three weeks alternating with oral methotrexate for three weeks, with a two-week rest)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Four-drug metronomic chemotherapy regimen
Number of subjects: 44
Study: 31156913

Group type: EXPERIMENTAL
Intervention: Pharmacist complex intervention (home visit at 1, 3, and 6 months) including medication review, medicines and lifestyle advice, PCI resolution, and supply of individualised patient information.
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Pharmacist complex intervention (home visit at 1, 3, and 6 months).
Number of subjects: 35

Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 35
Study: 26803316

Group type: EXPERIMENTAL
Intervention: Rectal cleansing enemas
Number of subjects: 59
Study: 24873024

Group type: EXPERIMENTAL
Intervention: Ostracized individuals
Number of subjects: 62

Group type: COMPARATOR
Intervention: Included individuals
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 62
Study: 22101207

Group type: EXPERIMENTAL
Intervention: Facebook recruitment
Number of subjects: 730

Group type: COMPARATOR
Intervention: Traditional recruitment methods
Number of subjects: 730
Study: 19880673

Group type: EXPERIMENTAL
Intervention: Intensive exercise and risk reduction therapy including educational sessions, a low‐fat diet, and 2 hours of individually prescribed exercise daily.
Number of subjects: 16

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 16
Study: 17456521

Group type: EXPERIMENTAL
Intervention: Integrated smoking cessation treatment within mental health care
Number of subjects: 1400

Group type: COMPARATOR
Intervention: Referral to specialized smoking cessation clinics (usual standard of care)
Number of subjects: 1400
Study: 15311146

Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP) therapy
Number of subjects: 122

Group type: COMPARATOR
Intervention: No CPAP therapy (control group)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: CPAP therapy
Number of subjects: 122
Study: 11136492

Group type: EXPERIMENTAL
Intervention: Nonthoracotomy ICDs via subclavian route
Number of subjects: 539

Group type: COMPARATOR
Intervention: Nonthoracotomy ICDs via cephalic vein route
Number of subjects: 539

Group type: EXPERIMENTAL
Intervention: Nonthoracotomy ICDs with abdominal generator site
Number of subjects: 539

Group type: COMPARATOR
Intervention: Nonthoracotomy ICDs with pectoral generator site
Number of subjects: 539

Group type: EXPERIMENTAL
Intervention: Failure to use perioperative antibiotics
Number of subjects: 539

Group type: EXPERIMENTAL
Intervention: Lead fractures
Number of subjects: 539

Group type: EXPERIMENTAL
Intervention: Routine ICD system surveillance
Number of subjects: 539
Study: 9634157

Group type: EXPERIMENTAL
Intervention: Intensive group treatment program (3 hours of group treatment, 3 days a week)
Number of subjects: 447

Group type: COMPARATOR
Intervention: Weekly individual outpatient counseling
Number of subjects: 447

Group type: COMPARATOR
Intervention: Weekly individual counseling plus one weekly group session
Number of subjects: 447

Group type: EXPERIMENTAL
Intervention: Patients who remained in treatment longer
Number of subjects: 447

Group type: EXPERIMENTAL
Intervention: Patients who remained in treatment
Number of subjects: 447
Study: 7608845

Group type: EXPERIMENTAL
Intervention: Tetracycline fiber therapy used adjunctively with scaling and root planing (S and RP)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Scaling and root planing (S and RP) alone
Number of subjects: 113
Study: 3362944

Group type: EXPERIMENTAL
Intervention: 0.75 ml/kg ethanol
Number of subjects: 20

Group type: COMPARATOR
Intervention: Isocaloric placebo
Number of subjects: 20
Study: 29617491

Group type: EXPERIMENTAL
Intervention: Elastic bandage and decongestant physical therapy
Number of subjects: 90

Group type: COMPARATOR
Intervention: Elastic bandage
Number of subjects: 90

Group type: COMPARATOR
Intervention: Primary dressing only
Number of subjects: 90
Study: 28232142

Group type: EXPERIMENTAL
Intervention: Parent coach-led well visits
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Well-Visit Planner
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Text message reminder/education service
Number of subjects: 115
Study: 26147818

Group type: EXPERIMENTAL
Intervention: DentalVibe Injection Comfort System (DV)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Traditional syringe (TS)
Number of subjects: 60
Study: 24105455

Group type: EXPERIMENTAL
Intervention: sirolimus (Rapamune 2 mg/d) for 14 days
Number of subjects: 38
Study: 22306103

Group type: EXPERIMENTAL
Intervention: Open Aneurysm Repair (OR)
Number of subjects: 334

Group type: COMPARATOR
Intervention: Endovascular Aneurysm Repair (EVAR)
Number of subjects: 334
Study: 19470885

Group type: EXPERIMENTAL
Intervention: Tadalafil 40 mg
Number of subjects: 405

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 405
Study: 18089878

Group type: EXPERIMENTAL
Intervention: Stem-cell transplant (SCT)
Number of subjects: 347

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 347
Study: 14981379

Group type: EXPERIMENTAL
Intervention: 800 microg of misoprostol with saline solution (group I, 41 women)
Number of subjects: 80

Group type: COMPARATOR
Intervention: 800 microg of misoprostol without saline solution (group II, 39 women)
Number of subjects: 80
Study: 11458251

Group type: EXPERIMENTAL
Intervention: Procosol sealer (PS)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: CRCS sealer (CR)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Sealapex sealer (SA)
Number of subjects: 204
Study: 9722720

Group type: EXPERIMENTAL
Intervention: Supragingival plaque control and oral hygiene instruction
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (Cerebral palsy patients)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Baseline examination
Number of subjects: 21
Study: 8822155

Group type: EXPERIMENTAL
Intervention: Hints in the form of the analogues' themes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Problem-oriented training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Memory-oriented training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hints in the transfer phase
Number of subjects: 0

Group type: COMPARATOR
Intervention: No-training control
Number of subjects: 0
Study: 1979615

Group type: EXPERIMENTAL
Intervention: Bisoprolol (10 mg)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Nitrendipine (20 mg)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Both bisoprolol and nitrendipine
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Nitrendipine
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Bisoprolol
Number of subjects: 36
Study: 6102235

Group type: EXPERIMENTAL
Intervention: Cryotherapy (intercostal block by freezing technique)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Local anaesthetics or no blockade (control group)
Number of subjects: 15
Study: 30885012

Group type: EXPERIMENTAL
Intervention: Enteral immunonutrition (EIN)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Standard enteral nutrition (SEN)
Number of subjects: 124
Study: 30561562

Group type: EXPERIMENTAL
Intervention: Eravacycline 1 mg/kg every 12 hours for 4-14 days
Number of subjects: 400

Group type: COMPARATOR
Intervention: Meropenem 1 g every 8 hours for 4-14 days
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Eravacycline
Number of subjects: 400

Group type: COMPARATOR
Intervention: Meropenem
Number of subjects: 400
Study: 27716665

Group type: EXPERIMENTAL
Intervention: DHA supplementation (2 g/day)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo (corn oil)
Number of subjects: 240
Study: 25935520

Group type: EXPERIMENTAL
Intervention: Fresh human milk applied to eczema spots, three times a day for four weeks
Number of subjects: 9

Group type: COMPARATOR
Intervention: Emollient applied to eczema spots, three times a day for four weeks
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Fresh human milk applied to eczema spots
Number of subjects: 9

Group type: COMPARATOR
Intervention: Emollient applied to eczema spots
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Fresh human milk samples
Number of subjects: 9
Study: 26491122

Group type: EXPERIMENTAL
Intervention: Nutrition counseling (breastfeeding promotion and increased intake of micronutrient-rich and energy-dense foods)
Number of subjects: 363
Study: 23382975

Group type: EXPERIMENTAL
Intervention: remifentanil (1 µg/ml)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: remifentanil (2 µg/ml)
Number of subjects: 43
Study: 21450224

Group type: EXPERIMENTAL
Intervention: Multifactorial fall prevention program (10 twice-weekly, 2-hour sessions with physical and psychological components and a booster session)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Usual geriatric care (control group)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Multifactorial fall prevention program
Number of subjects: 36
Study: 18342453

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen at 2.0 atmospheres absolute (Group 1)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Air at 1.1 atmospheres absolute (Group 2)
Number of subjects: 150
Study: 16873760

Group type: EXPERIMENTAL
Intervention: Intervention group (social inclusion program)
Number of subjects: 7594

Group type: COMPARATOR
Intervention: Comparison group (no intervention)
Number of subjects: 7594
Study: 12845362

Group type: EXPERIMENTAL
Intervention: Suction drain (Group A)
Number of subjects: 26

Group type: COMPARATOR
Intervention: No suction drain (Group B)
Number of subjects: 26
Study: 10831468

Group type: EXPERIMENTAL
Intervention: Adverse life events, sociotropy, and autonomy factor need for control
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Adverse interpersonal events (e.g., death of a loved one)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Multivariate model
Number of subjects: 86
Study: 9876895

Group type: EXPERIMENTAL
Intervention: Hybritech Tandem‐E PSA assay
Number of subjects: 182